Skip to main content

Table 3 Anogenital SPCs in CIN 2–3 LLETZ treated women. A comparison between literature and our study data

From: Risk of HPV-related extra-cervical cancers in women treated for cervical intraepithelial neoplasia

Author

Year

First lesion

Value

Vulva

Vagina

Anus

Evans [26]

2003

CIN 3

SIR

4.4

18.5

5.9

Kalliala [6]

2005

CIN 1–3

SIR

4.1

12

5.7

Edgren [9]

2007

CIN 3

IRR

2.2

6.7

4.7

Strander [22]

2007

CIN 3

RR

 

6.8

 

Saleem [12]

2007

CIN3

SIR

–

–

16.4

  

SCC

SIR

–

–

6.2

Tatti [27]

2012

CIN 2–3

OR

–

–

1.91

Gaudet [10]

2014

CIN 2

SIR

1.47

3.61

0.89

  

CIN 3

SIR

3.79

8.53

2.28

  

CIN2–3

SIR

2.9

6.65

1.75

Sand [11]

2016

CIN 2

RR

2.5

8.1

2.9

  

CIN 3

RR

4

17.1

4.2

Ebisch [8]

2017

CIN 3

IRR

4.97

86.08

3.85

Suk [23]

2018

SCC

SIR

3.8

17.3

2.3

Acevedo Fontánez [14]

2018

SCC

SIR

–

–

51.6

Wang [16]

2020

SCC

SIR

2.29

1.85

1.41

Our study

 

CIN 2–3

SIR

1.7

12.4

1.8

  1. Legenda:
  2. CIN Cervical Intraepithelial Neoplasia
  3. IRR Incidence Rate Ratio
  4. LLETZ Large Loop Excision of the Transformation Zone
  5. RR Relative Risk
  6. SCC Invasive Squamous Cell Carcinoma